Yishan Li

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Vincent Liptak, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Yishan Li

Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,714,117
Estimated value
Report date
10 Aug 2026
Price
Ownership
By The Li and Cui Family Trust
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,067,121
Estimated value
Report date
06 Aug 2026
Price
Ownership
By Spouse
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Common Stock
Shares / value
124,779
Estimated value
Report date
10 Aug 2026
Price
Ownership
By RongShan, LLC
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
112,701
Estimated value
Report date
06 Aug 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Series Angel Preferred Stock
Shares / value
0
Estimated value
Report date
10 Aug 2026
Price
Ownership
By The Li and Cui Family Trust
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
10 Aug 2026
Price
Ownership
By RongShan, LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive Chairman, Director, 10%+ Owner

BlossomHill Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
10 Aug 2026
Price
Ownership
By The Li and Cui Family Trust
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Yishan Li

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .